160 related articles for article (PubMed ID: 38418683)
1. Upadacitinib as Rescue Therapy for the Treatment of Acute Severe Colitis in an Acute Care Setting.
Clinton J; Motwani KK; Schwartz S; McCarthy P; Axelrad JE; Cross RK; George L
Dig Dis Sci; 2024 Apr; 69(4):1105-1109. PubMed ID: 38418683
[TBL] [Abstract][Full Text] [Related]
2. Upadacitinib Salvage Therapy for Infliximab-Experienced Patients with Acute Severe Ulcerative Colitis.
Gilmore R; Tan WL; Fernandes R; An YK; Begun J
J Crohns Colitis; 2023 Dec; 17(12):2033-2036. PubMed ID: 37422724
[TBL] [Abstract][Full Text] [Related]
3. Upadacitinib as a Rescue Therapy in Acute Severe Ulcerative Colitis: A Case Report and Review of the Literature.
Ali NM; Shehab MA
Am J Case Rep; 2023 Nov; 24():e940966. PubMed ID: 37926993
[TBL] [Abstract][Full Text] [Related]
4. The role of upadacitinib in the treatment of ulcerative colitis.
Jordan AA; Higgins PD
Immunotherapy; 2023 Jul; 15(10):713-727. PubMed ID: 37129377
[TBL] [Abstract][Full Text] [Related]
5. Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials.
Danese S; Vermeire S; Zhou W; Pangan AL; Siffledeen J; Greenbloom S; Hébuterne X; D'Haens G; Nakase H; Panés J; Higgins PDR; Juillerat P; Lindsay JO; Loftus EV; Sandborn WJ; Reinisch W; Chen MH; Sanchez Gonzalez Y; Huang B; Xie W; Liu J; Weinreich MA; Panaccione R
Lancet; 2022 Jun; 399(10341):2113-2128. PubMed ID: 35644166
[TBL] [Abstract][Full Text] [Related]
6. Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial Programme.
Raine T; Ishiguro Y; Rubin DT; Finney-Hayward T; Vladea R; Liu J; Phillips C; Cheng E; Targownik L; Loftus EV
J Crohns Colitis; 2024 May; 18(5):695-707. PubMed ID: 37942921
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis.
Sandborn WJ; Ghosh S; Panes J; Schreiber S; D'Haens G; Tanida S; Siffledeen J; Enejosa J; Zhou W; Othman AA; Huang B; Higgins PDR
Gastroenterology; 2020 Jun; 158(8):2139-2149.e14. PubMed ID: 32092309
[TBL] [Abstract][Full Text] [Related]
8. Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction Treatment.
Loftus EV; Colombel JF; Takeuchi K; Gao X; Panaccione R; Danese S; Dubinsky M; Schreiber S; Ilo D; Finney-Hayward T; Zhou W; Phillips C; Gonzalez YS; Shu L; Yao X; Zhou Q; Vermeire S
Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2347-2358.e6. PubMed ID: 36464141
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of upadacitinib for 16-week extended induction and 52-week maintenance therapy in patients with moderately to severely active ulcerative colitis.
Panaccione R; Danese S; Zhou W; Klaff J; Ilo D; Yao X; Levy G; Higgins PDR; Loftus EV; Chen S; Gonzalez YS; Leonard C; Hébuterne X; Lindsay JO; Cao Q; Nakase H; Colombel JF; Vermeire S
Aliment Pharmacol Ther; 2024 Feb; 59(3):393-408. PubMed ID: 38010661
[TBL] [Abstract][Full Text] [Related]
10. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
Yamamoto-Furusho JK; Uzcanga LF
Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study.
Festa S; Scribano ML; Pugliese D; Bezzio C; Principi M; Ribaldone DG; Allocca M; Mocci G; Bodini G; Spagnuolo R; Vernia P; Mazzuoli S; Costa F; Barberio B; Cosintino R; Zerboni G; Aratari A; Armuzzi A; Papi C
United European Gastroenterol J; 2021 May; 9(4):507-516. PubMed ID: 33259773
[TBL] [Abstract][Full Text] [Related]
12. Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data.
Danese S; Tran J; D'Haens G; Rubin DT; Aoyama N; Zhou W; Ilo D; Yao X; Sanchez Gonzalez Y; Panaccione R
Inflamm Bowel Dis; 2023 Nov; 29(11):1723-1729. PubMed ID: 36790041
[TBL] [Abstract][Full Text] [Related]
13. Improved outcome of acute severe ulcerative colitis while using early predictors of corticosteroid failure and rescue therapies.
Llaó J; Naves JE; Ruiz-Cerulla A; Gordillo J; Mañosa M; Maisterra S; Cabré E; Garcia-Planella E; Guardiola J; Domènech E
Dig Liver Dis; 2016 Jun; 48(6):608-12. PubMed ID: 27012443
[TBL] [Abstract][Full Text] [Related]
14. Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy.
Napolitano M; D'Amico F; Ragaini E; Peyrin-Biroulet L; Danese S
Drug Des Devel Ther; 2022; 16():1897-1913. PubMed ID: 35747444
[TBL] [Abstract][Full Text] [Related]
15. Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative Colitis.
Ghosh S; Sanchez Gonzalez Y; Zhou W; Clark R; Xie W; Louis E; Loftus EV; Panes J; Danese S
J Crohns Colitis; 2021 Dec; 15(12):2022-2030. PubMed ID: 34107013
[TBL] [Abstract][Full Text] [Related]
16. Update for surgeons on novel induction treatments for acute severe inflammatory bowel disease associated colitis.
Levar T; Johnston M; Ding NS; Behrenbruch C
ANZ J Surg; 2024 May; 94(5):795-803. PubMed ID: 38450582
[TBL] [Abstract][Full Text] [Related]
17. Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib.
Saruta M; Kawaguchi I; Ogawa Y; Sanchez Gonzalez Y; Numajiri N; Tang X; Miller R
J Med Econ; 2024; 27(1):566-574. PubMed ID: 38512101
[TBL] [Abstract][Full Text] [Related]
18. Tofacitinib for Rescue Therapy in Acute Severe Ulcerative Colitis: A Real-world Experience.
Kotwani P; Terdiman J; Lewin S
J Crohns Colitis; 2020 Jul; 14(7):1026-1028. PubMed ID: 32020189
[TBL] [Abstract][Full Text] [Related]
19. Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis.
Hoffmann P; Wehling C; Krisam J; Pfeiffenberger J; Belling N; Gauss A
World J Gastroenterol; 2019 Apr; 25(13):1603-1617. PubMed ID: 30983820
[TBL] [Abstract][Full Text] [Related]
20. Atopic Dermatitis and Ulcerative Colitis Successfully Treated with Upadacitinib.
Grieco T; Caviglia M; Cusano G; Sernicola A; Chello C; Del Duca E; Cantisani C; Taliano A; Sini N; Ianiro G; Pellacani G
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984542
[No Abstract] [Full Text] [Related]
[Next] [New Search]
